PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Mar-2026 Forlong Biotechology to Present Preclinical Data from FL115, a novel interleukin-15 (IL-15) superagonist, and FL116, a PD-1/interleukin-18 (IL-18) bispecific antibody, at the 2026 AACR Annual Meeting Businesswire
17-Mar-2026 Turquoise Health Announces $40 Million Series C to Become the Operating System for Healthcare Contracts and Payments Businesswire
17-Mar-2026 OPEX® Corporation to Showcase Advanced Warehouse Automation Solutions at MODEX 2026 Businesswire
17-Mar-2026 GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors Businesswire
17-Mar-2026 Biocom and Octane Announce Strategic Partnership to Accelerate Innovation Across California’s Life Science and Medtech Ecosystems Businesswire
17-Mar-2026 Lundbeck advances Parkinson’s research with new Phase 1b data at AD/PD™ 2026 Lundbeck
17-Mar-2026 R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease R1 Therapeutics
17-Mar-2026 BostonGene Named ‘Innovator of the Year’ at Boston Life Sciences Times Vanguard Awards Businesswire
17-Mar-2026 Panthera Joins the Association of Multisite Research Corporations (AMRC) Panthera
17-Mar-2026 GenesisCare announces the addition of an 8th systemic anti-cancer therapy service in Surrey GenesisCare
17-Mar-2026 Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies Businesswire
17-Mar-2026 Aro Biotherapeutics Reports Positive Phase 1b Topline Results for ABX1100, a Muscle-targeted GYS1 siRNA, in Patients with Late-Onset Pompe Disease (LOPD) Businesswire
17-Mar-2026 Cencora Announces Financial Leadership Transition Businesswire
17-Mar-2026 Man Cave Health Returns With No Cost PSA Screening to Lehigh Valley Auto Show with Partners Pocono Raceway and the Prostate Cancer Foundation Businesswire
17-Mar-2026 Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease Businesswire
17-Mar-2026 Vergent Bioscience Initiates Phase 3 VISUALIZE 2 Pivotal Study of Abenacianine (VGT-309) for Tumor Visualization During Lung Cancer Surgery Businesswire
17-Mar-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
17-Mar-2026 Cellino Appoints Ed Tekeian as Chief Operating Officer Businesswire
17-Mar-2026 Voro Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance PrimeBody™ Technology for Next-Generation Tumor-Activated ADCs Businesswire
17-Mar-2026 Scientists Introduce Technology to Control Ice Formation During Cell Freezing Businesswire